Bluejay Diagnostics Stock Alpha and Beta Analysis
| BJDX Stock | USD 3.75 0.23 6.53% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Bluejay Diagnostics. It also helps investors analyze the systematic and unsystematic risks associated with investing in Bluejay Diagnostics over a specified time horizon. Remember, high Bluejay Diagnostics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Bluejay Diagnostics' market risk premium analysis include:
Beta 0.45 | Alpha (0.88) | Risk 13.77 | Sharpe Ratio (0.06) | Expected Return (0.78) |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Bluejay |
Bluejay Diagnostics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Bluejay Diagnostics market risk premium is the additional return an investor will receive from holding Bluejay Diagnostics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Bluejay Diagnostics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Bluejay Diagnostics' performance over market.| α | -0.88 | β | 0.45 |
Bluejay Diagnostics expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Bluejay Diagnostics' Buy-and-hold return. Our buy-and-hold chart shows how Bluejay Diagnostics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Bluejay Diagnostics Market Price Analysis
Market price analysis indicators help investors to evaluate how Bluejay Diagnostics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bluejay Diagnostics shares will generate the highest return on investment. By understating and applying Bluejay Diagnostics stock market price indicators, traders can identify Bluejay Diagnostics position entry and exit signals to maximize returns.
Bluejay Diagnostics Return and Market Media
The median price of Bluejay Diagnostics for the period between Wed, Aug 28, 2024 and Tue, Nov 26, 2024 is 6.05 with a coefficient of variation of 30.14. The daily time series for the period is distributed with a sample standard deviation of 1.86, arithmetic mean of 6.18, and mean deviation of 1.51. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Acquisition by Zeidman Fred S of 2500 shares of Bluejay Diagnostics subject to Rule 16b-3 | 09/23/2024 |
2 | Bluejay Diagnostics stock hits 52-week low at 0.13 - Investing.com | 09/27/2024 |
3 | Disposition of 5324 shares by Jason Cook of Bluejay Diagnostics at 1.09 subject to Rule 16b-3 | 10/18/2024 |
4 | Bluejay Diagnostics stock plunges to 52-week low of 0.07 - Investing.com India | 11/14/2024 |
5 | Bluejay Diagnostics Implements 1-for-50 Reverse Stock SplitBluejay Diagnostics, Inc. recently announced a significant development in its corporate structure wit... | 11/22/2024 |
About Bluejay Diagnostics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Bluejay or other stocks. Alpha measures the amount that position in Bluejay Diagnostics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 (projected) | Payables Turnover | 1.59 | 1.69 | Days Of Inventory On Hand | 226.56 | 281.78 |
Bluejay Diagnostics Upcoming Company Events
As portrayed in its financial statements, the presentation of Bluejay Diagnostics' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Bluejay Diagnostics' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Bluejay Diagnostics' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Bluejay Diagnostics. Please utilize our Beneish M Score to check the likelihood of Bluejay Diagnostics' management manipulating its earnings.
| 18th of March 2024 Upcoming Quarterly Report | View | |
| 8th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 18th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Bluejay Diagnostics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Bluejay Stock Analysis
When running Bluejay Diagnostics' price analysis, check to measure Bluejay Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bluejay Diagnostics is operating at the current time. Most of Bluejay Diagnostics' value examination focuses on studying past and present price action to predict the probability of Bluejay Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bluejay Diagnostics' price. Additionally, you may evaluate how the addition of Bluejay Diagnostics to your portfolios can decrease your overall portfolio volatility.